Duroziez's disease

From WikiMD's Food, Medicine & Wellness Encyclopedia

Duroziez's disease is a rare medical condition characterized by a specific type of aortic regurgitation. It is named after the French physician Paul Louis Duroziez, who first described the condition in the 19th century. The disease is often associated with a distinctive murmur known as Duroziez's sign, which can be heard over the femoral artery.

Pathophysiology[edit | edit source]

Duroziez's disease involves the improper closure of the aortic valve, leading to the backflow of blood from the aorta into the left ventricle during diastole. This backflow increases the workload on the left ventricle, which can lead to left ventricular hypertrophy and eventually heart failure if left untreated.

Clinical Features[edit | edit source]

The hallmark of Duroziez's disease is the presence of Duroziez's sign, a double murmur heard over the femoral artery when it is compressed. Other symptoms may include:

Diagnosis[edit | edit source]

The diagnosis of Duroziez's disease is primarily clinical, based on the presence of Duroziez's sign and other symptoms of aortic regurgitation. Echocardiography is often used to confirm the diagnosis and assess the severity of the regurgitation. Additional diagnostic tools may include:

Treatment[edit | edit source]

The treatment of Duroziez's disease focuses on managing the symptoms and preventing complications. Medical management may include:

In severe cases, surgical intervention such as aortic valve replacement may be necessary.

Prognosis[edit | edit source]

The prognosis of Duroziez's disease varies depending on the severity of the aortic regurgitation and the patient's overall health. Early diagnosis and appropriate management are crucial for improving outcomes.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD